The epidemiology of benign prostatic hyperplasia: a study in Greece

被引:0
作者
Signorello, LB
Tzonou, A
Lagiou, P
Samoli, E
Zavitsanos, X
Trichopoulos, D
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Ctr Canc Prevent, Boston, MA 02115 USA
[3] Univ Athens, Sch Med, Dept Hyg & Epidemiol, Athens, Greece
关键词
benign prostatic hyperplasia; epidemiology; risk factors; sexual activity;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the epidemiology of benign prostatic hyperplasia (BPH) in a case-control study in greater Athens, Greece. Patients and methods The study comprised 184 patients surgically treated For BPH within one year of its diagnosis (cases) and 246 patients with no symptoms of BPH who were treated in the same hospitals for minor diseases or conditions (controls). All cases and controls were permanent residents of the greater Athens area, Greece. The data were assessed using unconditional logistic regression. Results After controlling for age and education, cases and controls had similar distributions for height, body mass index, sibship size and birth order in the parental family, marital status, number of offspring and a series of previous medical diagnoses or surgical operations, The sole exception was surgery for haemorrhoids, that appeared to be related to the incidence of BPH, possibly by chance. There was no evidence that vertex baldness, tobacco smoking, alcohol consumption or coffee drinking increased the risk for BPH. Men who had spent most of their lives in a rural rather than an urban environment appeared to be at reduced risk for BPH. Conclusion The lifestyle factors assessed here have no major effect on the aetiology of BPH.
引用
收藏
页码:286 / 291
页数:6
相关论文
共 50 条
  • [41] PSA and benign prostatic hyperplasia
    Grall, J
    Corbel, L
    ANNALES D UROLOGIE, 2004, 38 : S43 - S45
  • [42] Phytotherapy in Benign Prostatic Hyperplasia
    Kaynar, Mehmet
    Goktas, Serdar
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2014, 13 (04): : 236 - 240
  • [43] Herbs for benign prostatic hyperplasia
    Dvorkin, L
    Song, KY
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (09) : 1443 - 1452
  • [44] Association of the Benign Prostatic Hyperplasia and erectile dysfunction, the current treatment modalities in Benign Prostatic Hyperplasia
    Sen, Volkan
    Demir, Omer
    Esen, Ahmet Adil
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (04): : 62 - 64
  • [45] SHARED CARE FOR BENIGN PROSTATIC HYPERPLASIA - A FEASIBILITY STUDY
    MORRIS, SB
    POGSON, C
    SHEARER, RJ
    BRITISH JOURNAL OF UROLOGY, 1995, 76 (01): : 77 - 80
  • [46] BENIGN PROSTATIC HYPERPLASIA - A POPULATION-BASED STUDY
    CHUTE, CG
    STEPHENSON, WP
    GUESS, HA
    LIEBER, M
    EUROPEAN UROLOGY, 1991, 20 : 11 - 17
  • [47] Exploring the causal relationship: bidirectional mendelian randomization study on benign prostatic hyperplasia and cardiovascular diseases
    Xiang, Nanyan
    Su, Shiqi
    Wang, Zeng
    Yang, Yong
    Chen, Boxi
    Shi, Rui
    Zheng, Tao
    Liao, Banghua
    Lin, Yifei
    Huang, Jin
    FRONTIERS IN GENETICS, 2024, 15
  • [48] Prostatic urethral length as a predictive factor for surgical treatment of benign prostatic hyperplasia: a prospective, multiinstitutional study
    Kim, Bum Soo
    Ko, Young Hwii
    Song, Phil Hyun
    Kim, Tae-Hwan
    Kim, Ki Ho
    Kim, Byung Hoon
    PROSTATE INTERNATIONAL, 2019, 7 (01) : 30 - 34
  • [49] Metabolic Syndrome and Benign Prostatic Hyperplasia/What Component of Metabolic Syndrome Is Related to Benign Prostatic Hyperplasia?
    Tarim, Bahar Arican
    Camur, Emre
    Kavukoglu, Ovunc
    Kosemen, Mete
    Ozgur, Yasemin
    Narter, Kamil Fehmi
    JOURNAL OF UROLOGICAL SURGERY, 2023, 10 (03): : 194 - 198
  • [50] Benign prostatic hyperplasia and cardiovascular risk: a prospective study among Chinese men
    Wang, Xiaowen
    Su, Yang
    Yang, Chao
    Hu, Yonghua
    Dong, Jia-Yi
    WORLD JOURNAL OF UROLOGY, 2022, 40 (01) : 177 - 183